Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies

BACKGROUND: Prenatal screening for chromosome aneuploidies have constantly been evolving, especially with the introduction of cell-free fetal DNA (cfDNA) screening in the most recent years. This study compares the performance, costs and timing of test results of three cfDNA screening implementation...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Pregnancy Childbirth
Auteurs principaux: Huang, Tianhua, Gibbons, Clare, Rashid, Shamim, Priston, Megan K., Bedford, H. Melanie, Mak-Tam, Ellen, Meschino, Wendy S.
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2020
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7686697/
https://ncbi.nlm.nih.gov/pubmed/33228595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12884-020-03394-w
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires